作者
Burt Nabors,Jona A. Hattangadi‐Gluth,Craig Horbinski,Jana Portnow
摘要
Journal Article Accepted manuscript NCCN CNS Tumor Guidelines Update for 2024 Get access Louis Burt Nabors, MD, Louis Burt Nabors, MD Professor and Director, Department of Neurology, Division of Neuro-oncology, Vice Chair for Research, Department of Neurology and Neurosurgery, O'Neal Comprehensive Cancer Center, Heersink School of Medicine, University of Alabama at Birmingham, 510 20th Street South, FOT 1020, Birmingham, AL Corresponding: [email protected] https://orcid.org/0000-0001-5926-2230 Search for other works by this author on: Oxford Academic PubMed Google Scholar Jona Hattangadi-Gluth, MD, Jona Hattangadi-Gluth, MD Department of Radiation Medicine and Applied Sciences, Moores Cancer Center, University of California San Diego https://orcid.org/0000-0001-8222-606X Search for other works by this author on: Oxford Academic PubMed Google Scholar Craig Horbinski, MD, PhD, Craig Horbinski, MD, PhD Robert H. Lurie Comprehensive Cancer Center, Northwestern University https://orcid.org/0000-0001-8340-9992 Search for other works by this author on: Oxford Academic PubMed Google Scholar Jana Portnow, MD Jana Portnow, MD Department of Medical Oncology and Research Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, California Search for other works by this author on: Oxford Academic PubMed Google Scholar Neuro-Oncology, noae267, https://doi.org/10.1093/neuonc/noae267 Published: 18 December 2024 Article history Received: 19 November 2024 Published: 18 December 2024